Cargando…

Clinical efficacy of neoadjuvant chemohormonal therapy combined with laparoscopic radical prostatectomy in high-risk Prostate Cancer

OBJECTIVES: To evaluate the clinical efficacy of neoadjuvant chemohormonal therapy (NCHT) combined with laparoscopic radical prostatectomy in high-risk prostate cancer (PCa). METHODS: A randomized controlled trial was used in this study. Eighty patients with high-risk PCa treated in Tangshan Gongren...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Peng, Cai, Shengyong, Yan, Chengquan, Li, Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Professional Medical Publications 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676598/ https://www.ncbi.nlm.nih.gov/pubmed/36415258 http://dx.doi.org/10.12669/pjms.38.8.5469

Ejemplares similares

Neoadjuvant Chemohormonal Therapy before Radical Prostatectomy for Japanese Patients with High-Risk Localized Prostate Cancer
por: Sasaki, Takeshi, et al.
Publicado: (2021)

Neoadjuvant Chemohormonal Therapy in Prostate Cancer Before Radical Prostatectomy: A Systematic Review and Meta-Analysis
por: Ge, Qingyu, et al.
Publicado: (2022)

Cytoreductive radical prostatectomy after chemohormonal therapy in patients with primary metastatic prostate cancer
por: Babst, Christa, et al.
Publicado: (2022)

Significance of pelvic lymph node dissection during radical prostatectomy in high-risk prostate cancer patients receiving neoadjuvant chemohormonal therapy
por: Iwamura, Hiromichi, et al.
Publicado: (2022)

Comparison of neoadjuvant chemohormonal therapy vs. extended pelvic lymph-node dissection in high-risk prostate cancer treated with robot-assisted radical prostatectomy
por: Oishi, Takuya, et al.
Publicado: (2023)

Efficacy and Safety of Neoadjuvant Luteinizing Hormone-Releasing Hormone Antagonist and Tegafur-Uracil Chemohormonal Therapy for High-Risk Prostate Cancer
por: Sugino, Fumiya, et al.
Publicado: (2023)

Short-term clinicopathological outcome of neoadjuvant chemohormonal therapy comprising complete androgen blockade, followed by treatment with docetaxel and estramustine phosphate before radical prostatectomy in Japanese patients with high-risk localized prostate cancer
por: Narita, Shintaro, et al.
Publicado: (2012)

Combination Chemohormonal Therapy in Metastatic Salivary Duct Carcinoma
por: Jeong, Il Seok Daniel, et al.
Publicado: (2020)

Neoadjuvant hormonal therapy is a feasible option in laparoscopic radical prostatectomy
por: Naiki, Taku, et al.
Publicado: (2012)

CT‐based assessment of body composition following neoadjuvant chemohormonal therapy in patients with castration‐naïve oligometastatic prostate cancer
por: Sheikhbahaei, Sara, et al.
Publicado: (2020)

Impact of nuclear YAP1 expression in residual cancer after neoadjuvant chemohormonal therapy with docetaxel for high-risk localized prostate cancer
por: Matsuda, Yoshinori, et al.
Publicado: (2020)

Analysis of risk factors for positive surgical margin after laparoscopic radical prostatectomy with and without neoadjuvant hormonal therapy
por: Wang, Fangming, et al.
Publicado: (2023)

Combined robotic radical prostatectomy and laparoscopic proctectomy for synchronous prostate and rectal cancer
por: Tully, Zachary, et al.
Publicado: (2022)

Cost effectiveness of chemohormonal therapy in patients with metastatic hormone-sensitive and non-metastatic high-risk prostate cancer
por: Aguiar, Pedro Nazareth, et al.
Publicado: (2017)

Laparoscopic radical prostatectomy
por: Lipke, Michael, et al.
Publicado: (2005)

Early serial circulating tumor DNA sequencing predicts the efficacy of chemohormonal therapy in patients with metastatic hormone-sensitive prostate cancer
por: Du, Xinxing, et al.
Publicado: (2023)

Neoadjuvant androgen-deprivation therapy with radical prostatectomy for prostate cancer in association with age and serum testosterone
por: Akitake, Naoko, et al.
Publicado: (2018)

Laparoscopic radical prostatectomy with no anastomosis
por: Vazquez-Martul, Dario, et al.
Publicado: (2019)

A Meta-analysis of Robot Assisted Laparoscopic Radical Prostatectomy Versus Laparoscopic Radical Prostatectomy
por: Wang, Tao, et al.
Publicado: (2019)

The prevalence and outcomes of pT0 disease after neoadjuvant hormonal therapy and radical prostatectomy in high-risk prostate cancer
por: Joung, Jae Young, et al.
Publicado: (2015)

Feasibility of Neoadjuvant Ad‐REIC Gene Therapy in Patients with High‐Risk Localized Prostate Cancer Undergoing Radical Prostatectomy
por: Kumon, Hiromi, et al.
Publicado: (2015)

Neoadjuvant hormone therapy following treatment with robotic-assisted radical prostatectomy achieved favorable in high-risk prostate cancer
por: Hou, Cheng-Pang, et al.
Publicado: (2014)

Androgen deprivation therapy plus apalutamide as neoadjuvant therapy prior radical prostatectomy for patients with unresectable prostate cancer
por: Wei, Yongbao, et al.
Publicado: (2023)

Laparoscopic Radical Prostatectomy Alone or With Laparoscopic Herniorrhaphy
por: Celik, Orcun, et al.
Publicado: (2015)

Preoperative nutritional evaluation of prostate cancer patients undergoing laparoscopic radical prostatectomy
por: Shu, Wang, et al.
Publicado: (2022)

Neoadjuvant Chemotherapy prior to Radical Prostatectomy for Patients with High-Risk Prostate Cancer: A Systematic Review
por: Sfoungaristos, Stavros, et al.
Publicado: (2013)

Combined Robotic-Assisted Laparoscopic Partial Nephrectomy and Radical Prostatectomy
por: Patel, Manish N., et al.
Publicado: (2009)

Neoadjuvant androgen deprivation therapy combined with abiraterone acetate in patients with locally advanced or metastatic prostate cancer: When to perform radical prostatectomy?
por: Xu, Ziyang, et al.
Publicado: (2022)

Update on Robotic Laparoscopic Radical Prostatectomy
por: Matsunaga, Garrett S., et al.
Publicado: (2006)

Radical Prostatectomy and Intraoperative Radiation Therapy in High-Risk Prostate Cancer
por: Marchioro, Giansilvio, et al.
Publicado: (2012)

Outcomes of laparoscopic salvage radical prostatectomy after primary treatment of prostate cancer
por: Catarino, Raquel, et al.
Publicado: (2022)

AB140. Efficacy of radical prostatectomy combined with neoadjuvant chemotherapy in the treatment of locally advanced prostate cancer: preliminary experiences from a single center
por: Xue, Wei, et al.
Publicado: (2016)

Radical Prostatectomy: An Option for High-Risk Prostate Cancer
por: Rausch, S., et al.
Publicado: (2012)

Role of Radical Prostatectomy for High-Risk Prostate Cancer
por: You, Dalsan, et al.
Publicado: (2010)

The role of radical prostatectomy in high-risk prostate cancer
por: Chung, Byung Ha
Publicado: (2013)

Radical prostatectomy for high-risk prostate cancer | Opinion: NO
por: Ghodoussipour, Saum, et al.
Publicado: (2019)

Two Different Surgical Approaches for Prostatic Stromal Sarcoma: Robot-Assisted Laparoscopic Radical Prostatectomy and Open Radical Cysto-Prostatectomy With Ileal Conduit
por: Choi, Seock Hwan, et al.
Publicado: (2014)

Neoadjuvant Hormonal Therapy Preceding Radical Prostatectomy for Clinically Localized Prostate Cancer: Early Postoperative Complications and Biochemical Recurrence
por: Yang, Seung Woo, et al.
Publicado: (2011)

AB10. Laparoscopic radical anatomy of prostatectomy
por: Liang, Chao-Zhao
Publicado: (2014)

Learning Curve of Robot-Assisted Laparoscopic Radical Prostatectomy for a Single Experienced Surgeon: Comparison with Simultaneous Laparoscopic Radical Prostatectomy
por: Ku, Ja Yoon, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_iikaim2btfglqa9smlgci8ea5t